Al-Ola Abdallah, Associate Professor and Plasma Cell Disorder Program Director of the Division of HMCT at the University of Kansas Medical Center, shared a post on LinkedIn:
“Dr. Sites gave me a celebratory fist bump after my patient told him I convinced her to go for CAR-T when she was hesitant — and that it ended up being the best decision she ever made.”
More posts about Myeloma.